128 results on '"CHIN, Melvin"'
Search Results
2. Improving Medication Safety in Cancer Services for Ethnic Minority Consumers: Protocol for a Pilot Feasibility and Acceptability Study of a Co-Designed Consumer Engagement Intervention
3. Assessing suitability for long-term colorectal cancer shared care: a scenario-based qualitative study
4. Standard-Dose Osimertinib in EGFR-Mutated Non–Small-Cell Lung Adenocarcinoma With Leptomeningeal Disease
5. ‘Making it Meaningful’: Co-designing an intervention to improve medication safety for people from culturally and linguistically diverse backgrounds accessing cancer services.
6. Improving Medication Safety in Cancer Services for Ethnic Minority Consumers: Protocol for a Pilot Feasibility and Acceptability Study of a Co-Designed Consumer Engagement Intervention (Preprint)
7. Randomized Evaluation of Cognitive-Behavioral Therapy and Graded Exercise Therapy for Post-Cancer Fatigue
8. Correlation between initial tumour volume and treatment duration on Dabrafenib: observation study of subjects with BRAF mutant melanoma on the BRF112680 trial
9. Kiosk 9Q-FA-02 - Utility of CMR in Diagnosis of Metastatic Cardiac Melanoma
10. Data Supplement from Dose Selection, Pharmacokinetics, and Pharmacodynamics of BRAF Inhibitor Dabrafenib (GSK2118436)
11. Targeting treatment for colorectal cancer: The EGFR antibody story
12. Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer
13. Durvalumab and multimodality therapy in a patient with multiple recurrent and unresectable cutaneous squamous cell carcinoma
14. A matter of (good) timing: Dynamic biomarker discovery in immune checkpoint blockade
15. Codesigning consumer engagement strategies with ethnic minority consumers in Australian cancer services: the CanEngage Project protocol
16. Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer
17. Additional file 1 of Assessing suitability for long-term colorectal cancer shared care: a scenario-based qualitative study
18. Telemedicine in The Context of Covid-19- A Qualitative Study of Cancer Patients and Clinicians
19. Challenges and solutions to sharing a cancer follow-up e-care plan between a cancer service and general practice
20. What does co-design mean for Australia
21. Use of neostigmine in capecitabine-induced paralytic ileus
22. Additional file 2: of Using behaviour change and implementation science to address low referral rates in oncology
23. Additional file 1: of Using behaviour change and implementation science to address low referral rates in oncology
24. Development of an interactive, web-based shared care plan to facilitate the follow-up care of colorectal cancer patients
25. “Can I still get a tattoo?” Patients’ experiences across the clinical trajectory for metastatic melanoma: a dynamic narrative model of patient journey
26. Lipid lowering therapy in patients with HIV infection
27. Use and abuse of intracavernosal injections
28. Primary pancreatic lymphoma – pancreatic tumours that are potentially curable without resection, a retrospective review of four cases
29. Using behaviour change and implementation science to address low referral rates in oncology
30. The plot thickens: Archetypal narrative structure in the melanoma patient journey
31. Sharing Colorectal Cancer Follow-Up Using an E-Care Plan Between Cancer Services and Primary Health Care.
32. Patient, oncologist and GP views about cancer follow-up care in general practice
33. Patient, general practitioner and oncologist views regarding long-term cancer shared care
34. Patient, general practitioner and oncologist views regarding long-term cancer shared care
35. Dexamethasone Modifies Cystatin C-Based Diagnosis of Acute Kidney Injury During Cisplatin-Based Chemotherapy
36. Factors impacting treatment choice in the first-line treatment of colorectal cancer
37. Treatment of breast cancer 2 (BRCA2)-mutant follicular dendritic cell sarcoma with a poly ADP-ribose polymerase (PARP) inhibitor: a case report
38. The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population‐Based Multicenter Study
39. Achieving behaviour change for detection of Lynch syndrome using the Theoretical Domains Framework Implementation (TDFI) approach: a study protocol
40. Patient, general practitioner and oncologist views regarding long-term cancer shared care.
41. Rationale for treatment durations of targeted cancer agents
42. Dose Selection, Pharmacokinetics, and Pharmacodynamics of BRAF Inhibitor Dabrafenib (GSK2118436)
43. Cutaneous metastasis of prostate carcinoma treated with radiotherapy: a case presentation
44. Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment
45. What does co-design mean for Australia's diverse clinical workforce?
46. Phase I study of everolimus in combination with fluvastatin and zoledronic acid in patients with solid tumours.
47. Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer
48. Primary pancreatic lymphoma – pancreatic tumours that are potentially curable without resection, a retrospective review of four cases
49. Letters to the Editor.
50. Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.